Publications by authors named "Jeremy Raymond"

Claim this Profile
T
Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin.
Jérémy H Raymond, Zackie Aktary, Marie Pouteaux, Valérie Petit, Flavie Luciani

Nature· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proneural-Mesenchymal hybrid glioblastoma cells are resistant to therapy and dependent on nuclear import.
Guillaume Bourmeau, Oceane Anezo, Jeremy Raymond, Alberto Ballestín, Cathy Pichol-Thievend

Neuro Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin.
Jérémy H Raymond, Zackie Aktary, Marie Pouteaux, Valérie Petit, Flavie Luciani

Nature· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State.
Eleanor Johns, Yilun Ma, Pakavarin Louphrasitthiphol, Christopher Peralta, Miranda V Hunter, Jeremy H Raymond

Pigment Cell Melanoma Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UVB radiation suppresses Dicer expression through β-catenin.
Zackie Aktary, Valérie Petit, Irina Berlin, Jeremy Raymond, Frederique Berger

J Cell Sci· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The lipid droplet protein DHRS3 is a regulator of melanoma cell state.
Eleanor Johns, Yilun Ma, Pakavarin Louphrasitthipol, Christopher Peralta, Miranda V Hunter, Jeremy H Raymond

bioRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivation and Use of Cell Lines from Mouse Models of Melanoma.
Zackie Aktary, Jeremy H Raymond, Marie Pouteaux, Véronique Delmas, Valérie Petit

J Invest Dermatol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLEC12B Decreases Melanoma Proliferation by Repressing Signal Transducer and Activator of Transcription 3.
Henri Montaudié, Laura Sormani, Bérengère Dadone-Montaudié, Marjorie Heim, Nathalie Cardot-Leccia, Jérémy H Raymond

J Invest Dermatol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma.
Jérémy H Raymond, Zackie Aktary, Lionel Larue, Véronique Delmas

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRN2 is a non-canonical melanoma tumor-suppressor.
Michael Hamm, Pierre Sohier, Valérie Petit, Jérémy H Raymond, Véronique Delmas

Nat Commun· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Targeted Radionuclide Therapy Using [I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma.
Hussein Akil, Mercedes Quintana, Jérémy H Raymond, Tommy Billoux, Valentin Benboubker

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C57BL/6 congenic mouse NRAS melanoma cell lines are highly sensitive to the combination of Mek and Akt inhibitors in vitro and in vivo.
Valérie Petit, Jeremy Raymond, Christophe Alberti, Marie Pouteaux, Stuart J Gallagher

Pigment Cell Melanoma Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis